Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/2336
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGEUSENS, Piet-
dc.contributor.authorAlten, R.-
dc.contributor.authorRovensky, J-
dc.contributor.authorSloan, V-
dc.contributor.authorKrammer, G-
dc.contributor.authorKralidis, G-
dc.contributor.authorRichardson, P-
dc.date.accessioned2007-11-13T16:09:23Z-
dc.date.available2007-11-13T16:09:23Z-
dc.date.issued2003-
dc.identifier.citationARTHRITIS AND RHEUMATISM, 48(9). p. S242-S242-
dc.identifier.issn0004-3591-
dc.identifier.urihttp://hdl.handle.net/1942/2336-
dc.language.isoen-
dc.publisherWILEY-LISS-
dc.titleEfficacy, safety and tolerability of lumiracoxib in patients with rheumatoid arthritis: Results of a randomized double-blind study-
dc.typeJournal Contribution-
dc.identifier.epageS242-
dc.identifier.issue9-
dc.identifier.spageS242-
dc.identifier.volume48-
local.format.pages1-
local.bibliographicCitation.jcatM-
dc.description.notesBiomed Onderzoeksinst, Diepenbeek, Belgium. Schlosspk Klin, Berlin, Germany. Narodni Reumatol Ustav, Piestany, Slovakia. Novartis Pharmaceut Corp, E Hanover, NJ USA. Novartis Pharma AG, Basel, Switzerland.-
local.type.refereedRefereed-
local.type.specifiedMeeting Abstract-
dc.bibliographicCitation.oldjcatA5-
dc.identifier.isi000185432800588-
item.fulltextNo Fulltext-
item.accessRightsClosed Access-
item.contributorGEUSENS, Piet-
item.contributorAlten, R.-
item.contributorRovensky, J-
item.contributorSloan, V-
item.contributorKrammer, G-
item.contributorKralidis, G-
item.contributorRichardson, P-
item.fullcitationGEUSENS, Piet; Alten, R.; Rovensky, J; Sloan, V; Krammer, G; Kralidis, G & Richardson, P (2003) Efficacy, safety and tolerability of lumiracoxib in patients with rheumatoid arthritis: Results of a randomized double-blind study. In: ARTHRITIS AND RHEUMATISM, 48(9). p. S242-S242.-
crisitem.journal.issn0004-3591-
Appears in Collections:Research publications
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.